26 C
Vientiane
Friday, June 27, 2025
spot_img
Home Blog Page 243

EcoFlow Launches STREAM Series, the First U.S. Plug-and-Play Home Solar System Designed for Apartments and Condos in Addition to Single Family Homes

STREAM Series lets more people than ever enjoy solar power’s benefits of lower utility bills and home backup energy with an easy DIY setup

SEATTLE, May 7, 2025 /PRNewswire/ — EcoFlow, a leading portable power and eco-friendly energy solutions company, today introduces STREAM Series, the first plug-and-play home solar system available in the U.S. with a battery that can power your home.

Designed for homes with backyards, multifamily apartments and condos, STREAM Series can help cut electricity bills by harnessing solar energy for daily use. The system can be purchased with or without a battery. The battery version, STREAM Ultra, helps maximize energy savings and can provide critical backup power during a blackout.

STREAM will be available in Utah at launch, with plans to roll out this new product category in other states in the future. Utah’s rising electricity rates, strong solar potential and growing percentage of multi-family dwellings make STREAM Series a great option for residents seeking a plug-and-play, DIY solar solution with no installation, no complex setup and no utility approval needed.

“By launching Stream Series in Utah, we’re taking the first step in making renewable energy simple and accessible for people in the U.S. who have not been able to enjoy the benefits of residential solar,” said Brian Essenmacher, head of North American business development at EcoFlow.

“We’ve successfully launched this solution across Europe over the past two years with more than 120,000 units sold,” Essenmahcer said. “We’re now applying our global experience to bring flexible solar options to Americans beyond just single family homes. Plug-and-play home solar systems allow people to save on electric bills while avoiding the high costs, permitting and months-long installation timelines of traditional systems.”

How Does STREAM Series Work?

The EcoFlow STREAM series includes two key products: STREAM Ultra and STREAM Microinverter. The STREAM Ultra is a 1.92kWh solar battery with a built-in grid-tied microinverter — the first of its kind in the industry. The Microinverter converts solar energy directly into grid-ready electricity without energy storage capability.

The STREAM Ultra battery maximizes energy savings by storing excess solar power collected during daylight hours and making it available for regular use later or in the event of a power outage. STREAM Ultra can also collect 2000W of solar input, with 1,200W being directly fed into your home via the built-in microinverter, while any excess energy is stored in the battery.

For homes without energy storage needs, the optional standalone STREAM Microinverter converts solar energy directly into the home via a standard AC wall outlet up to 1,200W output. This energy is instantly available for use, helping to lower reliance on the grid and reduce utility bills.

This flexible system allows residents to position solar panels on balconies, patios, backyards and other outdoor spaces and harness their power in three configurations:

  • STREAM Ultra: Up to 2,000W of total solar input with up to 1,200W of it going directly to the home and the remainder for battery charging.
  • STREAM Microinverter: Up to 1,200W of solar power going directly to the home.
  • STREAM Ultra + STREAM Microinverter: Up to 3,200W of total solar input with up to 1,200W going directly to the home and up to 2,000W for battery charging.

Ultimate Electricity Cost Savings & Expandability

With one EcoFlow STREAM Ultra and one Microinverter, this plug-and-play setup can provide more than 6,000kWh of electricity per year, supplying approximately half of the average U.S. household’s needs and cutting bills by as much as $1,027 annually [note].

When multiple Ultra batteries are connected, the modular setup can expand from 1.92kWh to 11.52kWh and allows flexible battery placement. Powered by an AI-driven solar network, multiple batteries can work in sync — no matter where they’re located — to extend runtime, minimize grid reliance and eliminate solar waste. With its plug-and-play setup and intelligent energy flow management, households move closer to energy independence and zero electricity bills.

Smart Design. Smarter Energy Management

Built for long-lasting performance and everyday ease, STREAM Series features a clean, compact design that integrates seamlessly into modern homes. STREAM Ultra’s durable LFP battery retains 70% capacity even after 6,000 cycles and operates reliably in extreme temperatures down to -14°F. With a NEMA 4 rating for the Ultra battery and NEMA 6 for the Microinverter, the system is built to handle both indoor and outdoor conditions. Built-in safety mechanisms continuously monitor energy loads in real time, automatically adjusting power to stay within the 1200W limit and prevent tripping household circuits.

The STREAM Series is compatible with EcoFlow OASIS, an AI-powered energy management platform available through the EcoFlow app, designed to maximize home energy storage, prepare for weather-related power outages and reduce electric bills.

EcoFlow OASIS tracks real-time usage, generates detailed power usage reports, automatically optimizes charging based on Time-of-Use electricity pricing and provides smart recommendations to help lower costs. It also includes a multilingual 24/7 AI assistant that keeps users informed and in control and can answer product-related questions. With this intelligent layer, users gain full visibility and control over their energy production and consumption, making smarter energy decisions easier than ever.

Pricing & Availability

EcoFlow’s STREAM Series will be available for pre-order starting May 7 at an early-bird price, with official availability launching on July 14. To take advantage of the early-bird price, simply sign up with your email between May 7 and July 14. The early-bird offer will be valid until July 31.

*With dedicated 15A circuit.

Product

Early-Bird Price

MSRP

STREAM Ultra (battery)

$1199

$1899

STREAM Microinverter

$299

$599

STREAM Ultra and Microinverter

$1459

$2399

About EcoFlow:

EcoFlow is a leading provider of eco-friendly energy solutions, committed to powering a new world. Since its founding in 2017, EcoFlow has aimed to be the FIRST in power solutions — Flexible, Innovative, Reliable, Simple, and Thorough — for individuals and families, whether at home, outdoors or on the go. With a smart manufacturing center in China, and headquarters in the USA, Germany and Japan, EcoFlow has empowered over 5 million users in 140 markets worldwide. For more information, visit https://www.ecoflow.com/us.

Lunit to Power Germany’s Largest Private Radiology Network with AI Imaging

The five-year framework agreement covers phased rollout of Lunit’s AI suite—including chest X-ray, mammography, tomosynthesis, and fracture detection—across 79 Starvision sites

SEOUL, South Korea, May 7, 2025 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a strategic partnership with Starvision Service GmbH, Germany’s largest private radiology network. Through a newly signed framework agreement, Lunit’s AI imaging solutions will be deployed across Starvision’s expansive network of radiological practices.

Executives from Lunit and Starvision Service GmbH commemorate the signing of a supply agreement at the recent European Congress of Radiology (ECR 2025). From left to right: Dominik Guenzel, Regional Manager for DACH and Scandinavia at Lunit; Uwe Pfeifer, CEO of Starvision; Brandon Suh, CEO of Lunit; and Teri Thomas, Chief Business Officer at Lunit. (Photo: Lunit)
Executives from Lunit and Starvision Service GmbH commemorate the signing of a supply agreement at the recent European Congress of Radiology (ECR 2025). From left to right: Dominik Guenzel, Regional Manager for DACH and Scandinavia at Lunit; Uwe Pfeifer, CEO of Starvision; Brandon Suh, CEO of Lunit; and Teri Thomas, Chief Business Officer at Lunit. (Photo: Lunit)

Starvision operates 79 locations across seven German federal states, delivering services in radiology, nuclear medicine, and radiation therapy. As a recognized leader in the DACH healthcare market, Starvision is known for its commitment to digital transformation, operational excellence, and high-quality patient care.

Under the agreement, Starvision will adopt several of Lunit’s AI solutions, including:

  • Lunit INSIGHT CXR: AI-based chest X-ray analysis
  • Lunit INSIGHT MMG: Mammography analysis solution
  • Lunit INSIGHT DBT: Digital breast tomosynthesis interpretation
  • RBfracture: AI-driven fracture detection

The first commercial deployments are already underway—including use of Lunit INSIGHT MMG at Radiologische Allianz in Hamburg, supporting the Hamburg breast cancer screening program under the Starvision network. Together with deployments at Die Radiologie, a major regional hospital group operating over 20 medical sites across Bavaria, Lunit’s solutions are now supporting approximately 120,000 breast cancer screenings and diagnoses annually across the two institutions.

The five-year framework agreement allows additional Starvision locations—and newly affiliated practices—to join at any time, enabling broad scalability across the network. New deployments and clinical trials are already in progress, with individual agreements being signed across Starvision’s entities as part of a phased implementation plan. Beyond Starvision, several other healthcare providers across Germany have also expressed interest, reflecting the expanding demand for AI-driven imaging solutions.

“Lunit’s AI solutions support our radiologists in delivering fast and accurate diagnoses. This strengthens diagnostic confidence and gives us more time to focus on what truly matters: the individual care of our patients,” said Uwe Pfeifer, CEO of Starvision Service GmbH.

“Partnering with Starvision accelerates our vision of bringing AI-powered precision diagnostics into everyday clinical practice,” said Brandon Suh, CEO of Lunit. “Together, we are advancing a new era of radiology where technology enhances the expertise of physicians, delivering better outcomes for millions of patients in Germany and beyond.”

The partnership supports both companies’ vision of transforming healthcare through intelligent technology and setting new standards in radiology.

###

About Lunit

Founded in 2013, Lunit (KRX:328130.KQ) is a global leader in AI for cancer diagnostics and therapeutics. With a mission to conquer cancer through AI, Lunit develops AI-powered solutions for medical imaging and biomarker analysis to enable precise diagnosis and personalized treatment. Lunit’s FDA-cleared Lunit INSIGHT suite supports cancer screening at over 4,800 medical institutions in more than 55 countries. Lunit clinical studies have been featured in top-tier journals—including The Lancet Digital Health and Journal of Clinical Oncology—and presented at major conferences such as ASCO and RSNA. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.

Connext Successfully Completes Dose Escalation Part of CNT201 Phase 1/2 Clinical Trial for Dupuytren’s Contracture

– Conducted under U.S. FDA-cleared IND
– Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie’s disease

SEOUL, South Korea, May 7, 2025 /PRNewswire/ — Connext, a clinical stage biotechnology company, announced the successful completion of the dose escalation (Phase 1) part of its Phase 1/2 clinical trial for CNT201, its recombinant collagenase therapeutic for Dupuytren’s contracture. The trial was conducted in an open-label format and confirmed both the safety and efficacy of CNT201: no dose-limiting toxicities were observed, and clear therapeutic benefits were demonstrated.

Key Clinical Results and Future Plans

  • The study was conducted under a U.S. FDA-approved IND, using an open-label design to evaluate safety, tolerability, efficacy, pharmacokinetics, and immunogenicity.
  • The dose expansion (Phase 2) part is scheduled to begin in Q3 2025 as a double-blind study, aiming to demonstrate statistically significant efficacy.
  • Top-line data for the entire Phase 1/2 trial are expected in the first half of 2026, with plans to initiate global Phase 3 development in 2027.
  • The latest clinical development of CNT201 will be officially presented at the “International Conference on Dupuytren Disease and Related Diseases” in Brussels in May 2025.

Differentiation Through Innovative Recombinant Collagenase

Currently, Endo’s Xiaflex is the only commercially available collagenase injection for Dupuytren’s contracture. CNT201 is being developed as an alternative to Xiaflex and is expected to significantly improve patient access to non-surgical treatment. Collagenase is originally produced by fermentation of the pathogenic microorganism Clostridium histolyticum, which carries inherent risks of contamination with various toxins. In contrast, CNT201 is the world’s first recombinant collagenase therapeutic developed using genetic engineering technology, eliminating the risk of contamination from toxins or animal-derived substances. This ensures superior quality, consistent efficacy, and differentiated safety profiles.

Expanding Indications and Accelerating Global Drug Development

Connext is also pursuing a Phase 2 IND for Peyronie’s disease, based on the same mechanism of action, and aims to obtain U.S. FDA IND clearance in 2025. Additional development for aesthetic indications such as cellulite is also underway.

Statement from Woo Jong Lee, CEO of Connext

“By confirming both safety and efficacy in the dose escalation part of Phase 1/2 study, CNT201 offers a new non-surgical treatment option for patients with Dupuytren’s contracture. We aim to complete global new drug development with Phase 3 entry in 2027 and demonstrate the unique advantages of our innovative recombinant therapeutic,” said Woo Jong Lee, CEO of Connext.

Contact:
Sangho Lee, Head of Innovation
sangho.lee@connext.co.kr

Ampace Unveils Powerful New Battery System Ahead of Summer Storm Season Offering Week-Long Emergency Power for Families

The Extra Battery Expands Ampace Andes Portable Power Station for Extended Reliability in Any Crisis

LOS ANGELES, May 7, 2025 /PRNewswire/ — Ampace, a leader in lithium-ion power, today unveiled its advanced industrial-grade Ampace Andes 1500 Extra Battery, drastically expanding the capabilities of its flagship Ampace Andes 1500 Portable Power Station. Designed to provide uninterrupted power during emergencies, outdoor adventures, and extended outages, Ampace’s new battery extension arrives just in time for the anticipated summer storm season, ensuring families are never left in the dark.

Ampace Andes 1500 Extra Battery
Ampace Andes 1500 Extra Battery

Equipped with premium RESS (Residential Energy Storage System)-grade battery cells with a capacity of 1,462Wh at just 13kg, the system works seamlessly with the Ampace Andes 1500 Portable Power Station and supports connection of up to seven extended batteries, achieving a total capacity of 11,696Wh—enough to power an average household for up to a full week.

This cutting-edge battery system can sustain critical home appliances, high power tools and more—keeping entire households operational for up to a full week. The timing of this launch is particularly crucial, as weather forecasters predict a heighted frequency of severe weather events this year.

“At Ampace, we understand that dependable power isn’t just convenience, it is a necessity,” said Alfonso Chen, CMB Director of Ampace. “With Ampace Andes 1500 Extra Battery, we offer more than just power; we are providing peace of mind and potentially lifesaving reliability for thousands of families preparing for unexpected events.”

Like the Ampace Andes 1500 Portable Power Station, the Andes 1500 Extra Battery is built with RESS-grade battery cells, delivering exceptional portability without compromising on safety—setting a new standard for reliable power expansion. With industry-leading 55-minute rapid recharge technology and an extraordinary 6,000-cycle lifespan, it ensures like-new performance for over 15 years, even under intensive use.

Its rugged design withstands harsh temperatures (–4°F to 113°F) and includes a state-of-the-art mobile app for real-time monitoring, empowering users to manage their power needs seamlessly, whether sheltering at home during a storm or exploring off-grid adventures.

Featuring a built-in display, users can monitor the remaining battery level and charging time in real-time. The device includes integrated cable storage, keeping charging cords neatly organized and saving space. Its dual-handle design ensures effortless portability. Furthermore, the ports are equipped with foolproof protection to prevent incorrect connection.

The Ampace Andes 1500 Extra Battery is available now on Amazon for $599 or bundled with the Ampace 1500 Portable Power Station for $1,249. More details can be found at ampacepower.com.

About Ampace

Ampace Technology Limited (hereinafter referred to as “Ampace”) stands as a globally acclaimed innovator in new energy technologies, committed to delivering green energy solutions with ultimate user experience to forge the world ahead and empower a better life. In the realm of energy storage, e-mobility, power tools, vacuum cleaners, drones, and more, Ampace has established extensive strategic partnerships with industry leaders. The company is renowned for providing new energy products and services characterized by ultimate safety, reliability, performance, and user experience, serving over 50 million customers in 30 countries and regions worldwide.

About Ampace Andes

Ampace Andes is the flagship portable power brand under Ampace, built for extremes. Powered by over 20 years of innovation from Ampace—a global leader in energy storage—Ampace Andes delivers rugged, high-performance solutions designed to withstand the harshest environments. Whether in freezing cold or remote locations, Ampace Andes keeps your devices powered and your adventures going. Andes is more than a power station—it’s your dependable partner in facing the unpredictable. Ampace Andes — Powering the Extremes.

Contact: Xiaoning Chen, chenxn@ampacetech.com 

NYSE Content Advisory: Pre-Market update + Federal Reserve to release interest rate decision

NEW YORK, May 7, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on May 7th

  • Equities are fractionally higher Wednesday as markets anticipate the Federal Reserve’s next interest rate decision at 2 PM ET today. It is expected that the central bank will keep borrowing costs unchanged.
  • At 2:30 PM ET, Fed Chair Jerome Powell will meet with reporters to take their questions on the path forward amid tariffs and the current economic landscape.
  • Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer are expected to meet with their Chinese counterparts this week in Switzerland.

Opening Bell
Fortuna Mining Corp. (NYSE: FSM) celebrates the 20th anniversary of their founding.

Closing Bell
No Kid Hungry celebrates the launch of their summer campaign for kids, accompanied by many of their prominent CEO supporters.

Watch NYSE TV Live every weekday 9:00-10:00am ET

Video – https://mma.prnewswire.com/media/2681497/NYSE_Market_Update_May_7.mp4

Kaiyi Auto Sets Sail Its New Developing Strategy in Global Market

YIBIN, China, May 7, 2025 /PRNewswire/ — Kaiyi Auto has successfully held its Global Business Conference on April 28th. Themed “SAIL FOR FUTURE”, which was grandly held in Yibin, China, and brought together nearly 200 distributors from over 50 countries and regions. On the occasion, Kaiyi Auto announced its new strategy for global market.

During the conference, Jia Yaquan, the Chairman of Kaiyi Auto, extended warm welcome to the attendees and outlined the company’s five-year internationalization strategy in his speech.

Hu Jun–Executive Deputy General Manager of Kaiyi Auto, made a more detailed arrangement in the following speech: “To realize the goal increasing of annual production and sales volume from 60,000 to 500,000, Kaiyi Auto must stick to its ‘55511’ plan, focus on its core business, strengthen the brand image, and commit to long-term development.” The ‘55511’ plan refers to Kaiyi Auto’s 5 targets by 2030: achieving annual production and sales volume at 500,000 vehicles; output value of 50 Billion CNY; profit and tax of 5 Billion CNY simultaneously; new energy vehicles accounting for half of the total sales; and more than half of the sales coming from exports.

The Deputy General Manager of Kaiyi Auto, Jiang Sheng said Kaiyi Auto will launch five new models in the next five years, as well as update current ones.

Mr. Jiang also emphasized that for production and sales, Kaiyi Auto plans to establish a production structure of 6 CKD + 13 SKD by 2030, with an annual production capacity exceeding 300,000 units. By expanding into 80+ countries and regions supported by 1,000+ sales and service branches, Kaiyi Auto aims to build a channel network system for an annual sales target at 300,000 units, thus striving to rank among top 10 Chinese auto brands in exports.

“The next five years will be a period of rapid expansion, innovation, and shared success.” Han Ren, the deputy general manager of Kaiyi Auto and General Manager of Kaiyi Auto’s International Trade Company said.

This conference is a milestone in the internationalization of Kaiyi Auto Moving forward, Kaiyi Auto will join hands with global partners to usher in more technical innovation and business cooperation, inviting more international consumers to appreciate the charm of China’s intelligent manufacturing and products.

CTF Life Title-Sponsored “Fencing Plus” Training Programme by Kai Tak Sports Initiative Officially Kicks Off

Nearly 800 Students Participate in the Selection to Become Future World Champions


HONG KONG SAR – Media OutReach Newswire – 7 May 2025 – Title-sponsored by CTF Life and organised by Kai Tak Sports Initiative (KTSI), the “Fencing Plus” Training Programme (“Programme”) officially kicked off at the Kai Tak Arena Grand Hall on 4 May 2025 and marked the inaugural participation for CTF Life‧CIRCLE members. Through the holistic and structural development framework of the Programme, it aims to discover potential fencing athletes and cultivate a new generation of sports elites in Hong Kong, promoting the “Sports for All” culture and enhancing professionalism. Qualified apprentices will undergo a close to two-year structured training and can compete at the “Fencing Plus” Cup. Outstanding performers in the competition will receive professional training, and a chance to participate in the Hong Kong Under-14 Cadet Pre team. They will also have the opportunity to compete in the “Asian Youth Elite Fencing League”, supported by CTF Life, sharing the stage with fencers from around the world. An Experiential Day was also held on the Kick-Off Day, where the public participated in challenges to test their fitness skills, in preparation for next year’s registration for the programme.

Group photo at the press conference. Joining on stage includes Denise Au-Yeung, Chief Strategy Officer of CTF Life (third from the left); Director (Strategic Planning) of Kai Tak Sports Park (KTSP), King-shing Tang (third from the right); Chairman of the Hong Kong Fencing Association, Wing Sun Yeung (first from the left); Head Coach of the Programme, Antonio Lam (first from the right); Celebrities Panther Chan (second from the right) and Mike Tsang (second from the left).
Group photo at the press conference. Joining on stage includes Denise Au-Yeung, Chief Strategy Officer of CTF Life (third from the left); Director (Strategic Planning) of Kai Tak Sports Park (KTSP), King-shing Tang (third from the right); Chairman of the Hong Kong Fencing Association, Wing Sun Yeung (first from the left); Head Coach of the Programme, Antonio Lam (first from the right); Celebrities Panther Chan (second from the right) and Mike Tsang (second from the left).

Among the distinguished guests at the Kick-Off Ceremony to witness this significant moment were Chief Strategy Officer of CTF Life, Denise Au-Yeung; Director (Strategic Planning) of Kai Tak Sports Park (KTSP), King-shing Tang; Chairman of the Hong Kong Fencing Association, Wing Sun Yeung and Head Coach of the Programme, Antonio Lam. The event also invited Hong Kong fencing athletes, Moriah Man Ngai See (Sabre); Yeung Chi Ka (Foil) and Clarence Lai Ka Tsun (Epee) to demonstrate the basic techniques of the three disciplines and give guidance to the young apprentices on stage. Celebrities Panther Chan and Mike Tsang also performed songs to cheer for the young fencers and experienced fencing under the guidance of Antonio Lam.

CTF LifeCIRCLE Members join the Programme for the first time and enjoy unique experiences

Man Kit Ip, Executive Director and CEO of CTF Life, said, “Title-sponsoring the ‘Fencing Plus’ Training Programme by KTSI for the first time demonstrates our commitment to local sports development and offers opportunities for the next generation of athletes to shine on the international stage, creating value beyond sportsmanship. Furthermore, this edition marks the inaugural participation of CTF Life‧CIRCLE members, reflecting our dedication to delivering unique and high-quality diverse experiences for our customers.”

Director (Strategic Planning) of Kai Tak Sports Park, King-shing Tang, expressed appreciation to the title sponsorship of CTF Life during his speech, “KTSI is dedicated to advance sports for all for the Hong Kong community through sports and fitness related activities open to participants of all skill levels and ages. ‘Fencing Plus’ Training Programme is our major initiative, and we extend our special gratitude to CTF Life for their title sponsorship, supporting young athletes to undergo high-quality training and take part in competitions, cultivating a new generation of fencing athletes.”

Over 1,000 applicants aspire to become future fencers

The Programme received an enthusiastic response with over a thousand applications, including eligible children from underprivileged families whose participation was fully supported by CTF Life. The first stage of selection was held on the same day as the Kick-Off Ceremony, where about 800 successfully registered students participated in an interactive full-day test assessing their physical fitness abilities, including speed, agility and reflexes. Led by Head Coach, Antonio Lam, former Olympic Games representative of the Hong Kong Fencing Team and the Top Sabre Fencer in Hong Kong, he will guide a team of professional coaches to help apprentices build a solid foundation from the basic to the advanced levels through tailored instructions.

CTF Life will also arrange a series of sports-related workshops, spanning nutrition, physiotherapy, sports journalism and commentary, to help young talent unleash their potential and achieve all-round development.

As the exclusive Founding Insurance Partner of KTSP, the largest integrated sports and

entertainment landmark in Hong Kong, CTF Life will continue to be in support of KTSP’s pursuit in bringing international events to Hong Kong, reinforcing the city’s position as the “Events Capital of Asia”. CTF Life * CIRCLE members will have the opportunity to gain priority access to international sports and entertainment events, as well as community service initiatives organised or sponsored by the Company, and enjoy a wealth of unique experiences.

Details about the “Fencing Plus” Training Programme

Stage One: 4 May, 2025 Selection Day:

Select potential participants from nearly 800 children aged 6-10 for basic training

Stage Two: July-August 2025 Basic Training:

Comprehensive and structured basic fencing training, including postures and movements, physical fitness training, and education on fencing rules and etiquette

Stage Three: October-November 2025 Advanced Training:

Intensive and in-depth technical curriculum for participants who excel in the Basic Training to enhance their skills

Stage Four:

27-28 December 2025 (Tentative)

CTF Life “Fencing Plus” Cup and Celebration:

Put learning into practice during the competition and further experience the joy and challenges of competitive sports

Stage Five

Elite Training

Hashtag: #CTFLife

The issuer is solely responsible for the content of this announcement.

About CTF Life

Chow Tai Fook Life Insurance Company Limited (“CTF Life”) is proud of its rich, 40-year legacy in Hong Kong. CTF Life is a wholly-owned subsidiary of CTF Services Limited (“CTFS”) (Hong Kong Stock Code: 659) and one of the most well-established life insurance companies in Hong Kong. As a member of Chow Tai Fook Enterprises Limited, CTF Life consistently strengthens its collaboration with the diverse conglomerate of the Cheng family (“Chow Tai Fook Group” or “the Group”) to support customers and their loved ones in navigating life’s journey with personalised planning solutions, lifelong protection and diverse lifestyle experiences. By leveraging the Group’s robust financial strength and strategic investments across the globe, CTF Life aspires to become a leading insurance company in Asia while continuously creating value beyond insurance.

Nature’s Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment

ONTARIO, Calif., May 7, 2025 /PRNewswire/ — Nature’s Miracle Holding Inc. (OTCQB:NMHI) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology, today announced that the Company has entered into an equity purchase financing agreement (the “Financing”) with GHS Investments LLC (“GHS” or “Investor”).  The Company can require that the Investor invest up to Twenty Million Dollars ($20,000,000) to purchase the Company’s shares of common stock, $0.0001 par value per share (“Common Stock”) over the course of twenty-four (24) months immediately following the effective date of the registration statement to be filed with the Securities and Exchange Commission (“SEC”) in connection with the Financing, subject to the terms and conditions specified in the agreement. The Company issued 1,503,759 shares of Common Stock to the Investor in consideration for the Financing.  In addition, the Investor made a $250,000 investment in the Company’s Series A shares of preferred stock (the “Series A Shares”), which shares are convertible into shares of Common Stock at a conversion price of $0.112 per share.  The Company will be filing a registration statement to register all of the foregoing securities, and will file an 8-K providing additional information about the foregoing transactions.

About Nature’s Miracle Holding Inc.

Nature’s Miracle (www.Nature-Miracle.com) is a growing agriculture technology company providing products and services to growers in the Controlled Environment Agriculture (“CEA”) industry in the U.S.  The Company’s Common Stock trades on the OTCQB market (“OTCQB”) under the symbol “NMHI”.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: the intended use of proceeds from the offering; successful launch and implementation of Nature’s Miracle’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in Nature’s Miracle’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; Nature’s Miracle’s ability to develop and launch new products and services; Nature’s Miracle’s ability to successfully and efficiently integrate future expansion plans and opportunities; Nature’s Miracle’s ability to grow its business in a cost-effective manner; Nature’s Miracle’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of Nature’s Miracle’s business model; developments and projections relating to Nature’s Miracle’s competitors and industry; and Nature’s Miracle’s approach and goals with respect to technology.

These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on the OTC; changes in applicable laws or regulations; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which Nature’s Miracle’s operates; the risk that Nature’s Miracle’s and its current and future collaborators are unable to successfully develop and commercialize Nature’s Miracle’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that Nature’s Miracle’s is unable to secure or protect its intellectual property; the possibility that Nature’s Miracle’s may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in Nature’s Miracle’s filings from time to time with the SEC.